Clinical trials
Completed Fatigue Syndrome, Chronic trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
64 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 5 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 64 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Norwegian University of Science and Technology | 3 |
| Hacettepe University | 2 |
| Hospital Universitari Vall d'Hebron Research Institute | 2 |
| Icahn School of Medicine at Mount Sinai | 2 |
| Oslo University Hospital | 2 |
| Practitioners Alliance Network | 2 |
| Stony Brook University | 2 |
| Terra Biological LLC | 2 |
| US Department of Veterans Affairs | 2 |
| Aarhus University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fatigue Syndrome, Chronic | 64 |
| Fatigue | 20 |
| Fibromyalgia | 8 |
| Post-Acute COVID-19 Syndrome | 7 |
| Chronic Pain | 5 |
| Pain | 5 |
| Persian Gulf Syndrome | 3 |
| Anxiety Disorders | 2 |
| Irritable Bowel Syndrome | 2 |
| Mental Fatigue | 2 |
Trials
Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.